Objectives: Evaluation of feasibility and effectiveness of Surviving Sepsis Campaign (SSC)
Introduction
Severe sepsis represents a major cause of morbidity and mortality worldwide. The estimated mortality rate among patients with sepsis has been reported in the range of 17-50% [1] . However, early diagnosis coupled with appropriate treatment is the corner-stone to improving outcomes [2] [3] [4] [5] [6] [7] . The first wide-spread clinical practice guideline (CPG) for severe sepsis, namely Surviving Sepsis Campaign (SSC)-CPGs, was published in 2004, and then updated in 2007 and 2012 [8] [9] [10] . The Surviving Sepsis Campaign-Clinical Practice Guidelines (SSC-CPGs) were devised as a means for increasing health care provider awareness worldwide while simultaneously providing an optimal sepsis management model [9] . Different institutions throughout the world have demonstrated variable impacts on the outcomes of patients with severe sepsis after implementing the SSC-CPGs and its bundles [10] . However, the feasibility of implementing such guidelines in the Gulf Corporation Council region has not been reported.
The present quality improvement (QI) initiative evaluated the feasibility of adapting and implementing SSC-CPGs for managing sepsis/severe sepsis in children as well as its impact on the outcomes [mortality and length of stay (LOS)] in the Pediatric Intensive Care Unit (PICU) at a tertiary care university hospital in Saudi Arabia.
Methods
This retrospective data analysis of a prospective QI initiative was initiated by the PICU at King Khalid University Hospital (KKUH), King Saud University, Riyadh, Saudi Arabia. The SSC-CPGs for managing severe sepsis (2008) was adapted using a systematic method for adapting CPGs outlined in the ADAPTE Collaboration (2009): The ADAPTE process Resource toolkit was used to adapt the guidelines (Version 2.0; available from: http//www.g-i-n-net). The adapted guidelines were approved by our hospital CPGs committee. A QI initiative targeting the PICU, Pediatric Emergency and Pediatric Ward units was created after thorough discussion with quality management, infection control, clinical pharmacy and laboratory departments. We followed the Plan-Do-Check-Act cycles in our QI initiative. The aims of the QI initiative were to evaluate the feasibility of SSC-CPG implementation and clarify its potential impact on the outcome, sepsis-related mortality, and LOS through the early identification and appropriate management of sepsis in children.
Three months prior to implementation, an educational campaign for the adapted guidelines and its implementation process was delivered to health care providers in the PICU, Pediatric Emergency and Pediatric Ward. Moreover, educational brochures, rolls up for the adapted guidelines, a sepsis screening tool and time-scaled management algorithm forms were distributed to the health care providers. Furthermore, different resources, such as central venous catheters, intra-osseous needles and point of care testing, which might be needed for optimal implementation, were made readily available.
To expedite the delivery of medications, especially antibiotics and inotropes in septic patients, a medication turnaround time initiative was started as a part of pre-implementation requisite. This was to ensure proper implementation of the adapted sepsis guidelines and its bundle elements that included administration of antibiotic within 60 min in emergency units.
The initial antibiotics choice was based on our hospital antibiotic prescription policy and the suspected focus of infection, while further treatment was based on culture and sensitivity results and patient responses.
A team from the PICU was designated to follow the implementation process and check the health care provider compliance for its management steps. The adapted guidelines were implemented 24 h a day, 7 days a week. Data were collected using the predesigned implementation forms, sepsis screening tool and management algorithm. The management steps algorithm was used as a guide for the Table 1 Management steps algorithm in the post-implementation group
Management steps
Step I Recognize decreased mental status and perfusion; maintain airway and establish vascular access as per PALS guidelines
Step II Fluid resuscitation with saline push 20 ml/kg; correct hypoglycemia and hypocalcemia and administer antibiotics within 1st hour
Step III Assess if fluid responsive; PICU observation
Step IV If fluid refractory, establish CVC and start inotropic support (dopamine) with BP monitoring
Step V Assess if fluid refractory but dopamine responsive; continue PICU observation
Step VI If fluid refractory and dopamine resistant, start epinephrine for cold shock and norepinephrine for warm shock
Step VII Assess if catecholamine responsive shock; continue PICU observation
Step VIII If catecholamine resistant shock, start hydrocortisone a
Step IX Assess if persistent catecholamine resistant shock; titrate volume and inotropes according to patient condition
Step X Assess if refractory shock; consider ECMO N, number; SSC, surviving sepsis campaign; CPGs, clinical practice guidelines; PALS, pediatric advanced life support; PICU, pediatric intensive care unit; CVC, central venous catheter; ECMO, extracorporeal membrane oxygenation. physician orders according to patient progress and response ( Table 1) .
The QI initiative included all children <13 years of age who were admitted to the PICU between July 2010 and March 2011 with suspected or proven sepsis/severe sepsis and treated according to the adapted SSC-CPGs (post-guideline implementation group). Studied patients were prospectively enrolled from the Pediatric Emergency and Pediatric Ward upon consulting the pediatric intensive-care team for suspected or proven sepsis/severe sepsis. The early recognition of sepsis and organ failure was identified according to the SSC screening tool for sepsis and severe sepsis [7] . The diagnosis of sepsis was made by the attending physician and based on International Sepsis Definitions Conference criteria: suspected site of infection; two or more systemic inflammatory response syndrome criteria such as hypo-or hyperthermia, leukopenia, leukocytosis, tachycardia and tachypnea; and dysfunction of one or more organs [11] . Comparisons were made to patients admitted to the PICU with the diagnosis of sepsis/severe sepsis identified by the same criteria as the post-guideline implementation group over a period of 9 months (October 2009-June 2010) prior to SSC-CPG implementation (preguideline implementation group) by medical record review.
Demographic, clinical, laboratory and outcome data (mortality and PICU LOS) were collected for both groups. Moreover, data of the sepsis screening tool for the early identification of sepsis and of the management algorithm steps were collected to check for implementation process compliance; however, the detailed examination of compliance for the different bundle elements was beyond the scope of this pilot project. The statistical analysis was done using SPSS version 21 (IBM Corporation, USA). Descriptive statistics for continuous variables are expressed using median and interquartile range (IQR) or mean and standard deviation when appropriate, whereas categorical data are presented as percentages. To compare the two groups, the Mann-Whitney U test or independent t-test was used for quantitative non-parametric and parametric data, respectively, whereas the Pearson's chi-squared test was used for qualitative data. Differences were considered statistically significant at P < 0.05. A multivariate logistic regression models were built to adjust the study outcome for possible confounders such as age, sex, month of admission, immune status, systemic inflammatory response manifestations, focus of infection, number of failing organs, use of adapted guidelines and blood lactate level were tested for possible confounding effects.
We used two by two contingency table comparing mortality between the pre-and post-implementation groups to calculate mortality relative risk, absolute risk reduction and relative risk reduction.
The statistical analysis and detailed report until March 2011 represented the first cycle of our QI initiative. As a follow-up for the subsequent cycles, we reported the outcome of interest for this QI initiative, namely annual mortality rate associated with severe sepsis, until December 2016.
Ethics approval and consent to participate
The Institutional Review Board of King Saud University Medical City reviewed and approved this study and waived the need for consent as it is a QI initiative project that does not include any confidential patients' data.
Results
A total of 65 patients were included in the study (42 in the postguideline implementation group, 23 in the pre-guideline implementation group).
Compliance was achieved for the targeted step of the management algorithm. However, the time required to accomplish the targeted step was not reported. Moreover, further assessments of the detailed sepsis management bundle elements and its impact on the outcome measures were beyond the scope of this QI initiative. Table 2 shows the demographic, clinical and outcome measures of both groups. The median age was 18 months in both groups; no significant differences were found between the two groups in sex, immune status, clinical signs, site of infection or number of failed organs. Fewer deaths occurred in the post-guideline implementation group; however, the difference was not statistically significant ( In the univariate analysis, four statistically significant variables favored survival: implementation of the adapted guidelines, fewer organ failures, non-immunocompromised status, and blood lactate level ≤2 mmol/l. Several logistic regression analysis models for various confounders have been tested. Confounders such as age, sex, month of admission, immune status, systemic inflammatory response manifestations, focus of infection, number of failing organs, use of adapted guidelines and blood lactate level were tested for possible confounding effects. Only two variables showed statistical significance in the multivariate regression analysis as predictors of good outcomes: lower number of failing organs and the implementation of sepsis management guidelines (Table 3) . Figure 1 was derived from the multivariate regression model showing the death probability in relation to the total number of failing organs among the studied groups. It shows a lower probability of death among the post-guideline implementation group compared to the pre-guideline implementation group. At any point of the axis representing the total number of failing organs, the probability of death was lower in the post-guideline implementation group. Figure 2 shows the pre-and post-adapted guideline implementation mortality rates. A sustained lower mortality (average mortality rate, 15.11%) was noted among pediatric septic patients admitted to our PICU in the 5-years after guideline implementation (2012-16).
The average LOS for the 5-years after the initial implementation was 6.4 days compared with 5 days in the pre-implementation group and 7 days in the first post-implementation cycle. Compliance was achieved for the targeted step of the management algorithm. However, the time required to accomplish the targeted step was not reported. Moreover, further assessments of the detailed sepsis management bundle elements and its impact on the outcome measures were beyond the scope of this QI initiative.
Discussion
This study's findings support the feasibility and potential benefit of the implementation of the adapted SSC-CPG in our population and demonstrated clinically meaningful improvement in sepsis-related mortality rates. These findings are further supported after the adjustment for illness severity as measured by number of failing organs and revealed decreased mortality in the initial cycle for the post-sepsis guideline implementation group. Moreover, the lower sepsis-related mortality rate was sustained over the subsequent post-implementation years compared to the pre-implementation group and the initial postimplementation cycle.
These findings are consistent with other studies that documented decreased mortality from severe sepsis after the implementation of QI projects aimed at increasing the adherence to SSC-CPGs bundles in both emergency departments and intensive care units (ICUs) [10, [12] [13] [14] [15] [16] [17] [18] [19] . For instance, van Zanten et al. [19] published a prospective multicenter cohort study involving 82 ICUs in the Netherlands, reporting a 5.8% adjusted absolute mortality reduction over 3.5 years at centers where SSC bundles have been implemented. More recently, the data of the participating 218 ICUs over 7.5 years from SSC, an international collaborative initiative aiming to improve adherence to SSC-CPG, was published, and its analysis revealed lower mortality rates in high (29.0%) versus low (38.6%) resuscitation bundle compliance sites. This corresponded to a mortality rate decrease of 0.7% per site for every 3 months of participation [19] . However, in the current study, the larger number of patients included in the post-sepsis-guideline implementation group compared with the pre-sepsis guideline implementation group might have played a role in the decreased mortality rate in the post-sepsis guideline implementation group. One of the major goals of successful treatment of sepsis is the early recognition and adherence to treatment bundles. Hence, the QI initiative implementation program addressing these problems before progressing to late stages of septic shock might have impacted early treatment of such patients and led to consequently better outcomes compared to the preimplementation group.
Furthermore, the sustained lower mortality rate in the subsequent years could be attributed to better compliance with the implementation process and higher adherence of the health care providers to the management bundles.
In contrast, other studies reported relatively low mortality rates without SSC-CPG implementation, while others reported no statistically significant difference in mortality after SSC-CPG implementation. However, these studies either did not have a control group or were insufficiently powered to assess mortality benefits [20, 21] . Another possibility is that the impact or potential benefit of any given QI initiative is related to whether the center is at the lower or higher position in the curve of the desired improvement for the outcome before starting the QI project. For instance, a center that achieves a lower mortality rate with a narrow window of potential improvement may not show a similar benefit in a center that reports a high mortality rate with a larger window of potential improvement. Thus, the feasibility and potential benefit of guideline implementation could vary among different centers and regions.
On the other hand, controversies regarding the effectiveness of SSC-CPG are mainly based on the argument derived from the questionable effectiveness of early goal-directed therapy in sepsis reported by Rivers et al. [22] that represent an important component of the SSC-CPG. Two large randomized controlled trials recently failed to demonstrate a mortality benefit [23, 24] . The findings of these trials may trigger further modifications and improvements in the bundles of SSC-CPG through a careful examination of the effectiveness of each individual or combined bundle element.
The association between number of failing organs and mortality in our multivariate regression model agrees with those of other reports that correlated organ failure with death in cases of sepsis [24] [25] [26] [27] [28] . In a recent multicenter French epidemiological study, Pavon et al. [27] investigated mortality in adults diagnosed with septic shock and admitted to the ICU and concluded that organ dysfunction as measured by the Sequential Organ Failure Assessment had the greatest impact on early mortality after septic shock, while other co-morbidities may contribute to later mortality.
In the current study, we reported a non-significant shorter LOS at the PICU among the pre-guideline implementation group. A possible explanation for such a finding is that patients in the studied group were identified and enrolled in the study early; hence, they had a longer LOS. On the other hand, the pre-sepsis guideline implementation group could have been more ill when recognized as septic patients with late or irreversible stages of septic shock and consequently experience earlier death and a shorter LOS. However, due to the small sample size, especially in the pre-guideline implementation group, it is difficult to quantify such an impact with confidence.
On the other hand, other reports demonstrated shorter LOS after the implementation of SSC-CPG [24, 29] . In a recent SSC follow-up, Levy et al. [18] reported that hospital and ICU LOS for adults decreased 4% for every 10% increase in site compliance with the resuscitation bundle. Similarly, Larsen et al. [30] demonstrated a decline in median hospital LOS from 181 to 140 hours after the implementation of a pediatric septic shock protocol.
The association between improved outcomes and adapted SSC-CPG implementation at our hospital could be related to the early identification of sepsis/severe sepsis that resulted in early initiation of appropriate treatment for such patients before the progression to late or irreversible stages of shock. One more factor could be adherence to implementation of the management bundle elements according to the adapted SSC-CPG, such as adequate fluid resuscitation, early initiation of antibiotic therapy, and optimization of vasoactive medications in the PICU setting, which agrees with some other reports. Ferrer et al. [31] [32] [33] [34] recently published a report from SSC data and found a linear increase in the risk of mortality for each hour delay in antibiotic administration. However, in the present study, an examination of compliance with the detailed sepsis management bundle elements was beyond the scope of this QI initiative in this phase.
Similar to other studies, the present study found that the highest incidence of sepsis is encountered in infants and gradually decreases with increasing age [35, 36] . Nevertheless, in our study, patient age failed to predict mortality in the univariate or multivariate analysis. Planning, communication and preparation prior to implementation of the adapted CPG are essential to ensure proper utilization and adherence to the guideline implementation. Therefore, in these settings and prior to implementation, the following tools were utilized to increase awareness and improve performance managing children with severe sepsis: pre-implementation education, orientation lectures, use of a sepsis screening tool, distribution of management algorithm brochures to health care providers, attachment of the management algorithm to the emergency sheet and in the PICU chart when sepsis is suspected, and improving communication and cooperation among different teams through early consultation with an intensive care team. We believe that these measures played a considerable role in eliminating or minimizing barriers to SSC-CPG implementation in our settings. Indeed, other authors proposed similar measures to improve adherence for implementing these guidelines [37] [38] [39] .
Other studies elicited lower adherence rates with the guidelines outside critical care units that included the emergency department and pediatric ward, where patients usually present first. Common limitations of implementing the guidelines in these areas included: delayed recognition of sepsis, relative delay in the delivery of antibiotics beyond the standard time and staff shortages [5, 40, 41] .
Mikkelsen et al. [41] analyzed factors that led to poor adherence to SSC-CPG and found that a lack of consultation of a sepsis specialized team service was among the independent risk factors for poor outcomes of severe sepsis. In our study, the early involvement of an intensive care team as a part of the QI initiative for the successful treatment of septic patients enabled the overcoming of some obstacles that might contribute to suboptimum adherence to different bundle elements pre-admission to the critical care unit.
The present study has some limitations. First, like most of the related and previously published studies, a previous group was used for comparison due to the infeasibility of prospective randomization in the presence of institutional and/or ethical restrictions involving the withholding of effective treatment.
The second limitation was the relatively small number of patients from a single center. However, this study is the first to examine the feasibility of the implementation of adapted SSC-CPGs in a Saudi pediatric population, which may enhance rapid adaptation of these CPGs in other hospitals across the country. Furthermore, the current study went beyond QI initiative and process improvement to reveal potential outcome-based benefits with a 5-year follow-up, which adds to previous studies in support of the use of SSC-CPGs.
Another limitation is the higher number of patients in the study group than in the comparison group. Although the recent expansion of bed capacity in our emergency department and PICU could be a contributing factor, it may also reflect an increase in awareness of caregivers regarding the early identification of septic patients, which might reflect a change in caregiver knowledge and attitudes about managing pediatric septic patients after implementation of the adapted guidelines. Furthermore, the high compliance rate to the management steps algorithm in this QI initiative can reflect the changes in the clinical practice of health care providers in our institute who manages pediatric septic patients.
Finally, being designed as a QI initiative for the feasibility of the implementation of adapted SSC-CPGs in children, the lack of a severity score in our study limits the comparison of our findings to those of other reported studies focusing on sepsis epidemiology and outcome. However, it adds insight into the pediatric population since most of previously published studies were adult-based or involved mixed adult and pediatric populations.
The findings of this QI initiative to adapt and implement SSCCPGs in our setting support the feasibility and potential benefits of implementing these guidelines. The reduced mortality rate observed in the post-guideline implementation group was sustained over the subsequent years. However, a future larger study is recommended to explore compliance with the detailed SSC-CPG bundle element implementation and determine the potential impact in the region.
